{"id":71080,"date":"2024-11-08T17:26:15","date_gmt":"2024-11-08T15:26:15","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=lay_language&p=71080"},"modified":"2024-11-08T17:27:19","modified_gmt":"2024-11-08T15:27:19","slug":"lipisomal-irinotecan-compared-to-standard-treatment","status":"publish","type":"lay_language","link":"https:\/\/www.ipsen.com\/lay-language\/lipisomal-irinotecan-compared-to-standard-treatment\/","title":{"rendered":"Lipisomal irinotecan compared to standard treatment"},"content":{"rendered":"\n
Lipisomal irinotecan compared to standard treatment in people whose lung cancer worsened after initial treatment<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","lay_language_category":[74109],"class_list":["post-71080","lay_language","type-lay_language","status-publish","has-post-thumbnail","hentry","entry"],"acf":[],"yoast_head":"\n